Effect of Full Use of Adult Immunizations. Vaccinations for Adult and Adolescent Women. Trends in Vaccine-Preventable Diseases Post Vaccine
|
|
- Hilda Cross
- 5 years ago
- Views:
Transcription
1 Vaccinations for Adult and Adolescent Women Eliseo J. Pérez-Stable, MD Professor of Medicine DGIM, Department of Medicine University of California, San Francisco July 3, 2013 Declaration of full disclosure: No conflict of interest Vaccines Available in the US Tetanus, Diptheria, Pertussis, Measles, Mumps, Rubella, Varicella, HPV, Polio Meningococcus, Pneumococcus, Influenza, Hepatitis B, Hepatitis A, H influenza, Rabies, Typhoid, Yellow Fever, Japanese encephalitis, Typhoid Effect of Full Use of Adult Immunizations Deaths/yr. Efficacy Use Prev Deaths/yr Influenza 36,000 70% 65% 18,000 Pneumonia 40,000 60% 60% 20,000 HBV 6,000 90% 30% 4,000 Tetanus-D < 25 99% 64% < 15 MMR < 30 95% varies < 30 Trends in Vaccine-Preventable Diseases Post Vaccine Measles and Rubella: 99.9% reduction (66 cases total and 1 case CRS in 2006) Tetanus: 93% reduction Pertussis: 92% reduction (recent increase) Hepatitis A: 87% reduction Acute HBV: 80% reduction Invasive pneumococcal disease: 34% cases and 25% mortality reduction Varicella: 85% reduction Roush SW, et al. JAMA 2007; 298:
2 Vaccination Coverage in US Adults by Age Groups, 2011 HPV: 29.5% women y Td or TDaP past 10 years: 64.5% (19-49 y), 63.9% (50-64 y), 54.4% ( 65 y) Hepatitis A: 12.5% (19-49 y) and 20.1% for those who travel outside US HBV: 35.9% (19-49 y) Pneumococcal: 20.1% (19-64 y), 62.3% ( 65 y) Varicella: 15.8% 60 y Health Care Staff: TDaP 26.8% and HBV 63.8% CDC, MMWR 2013; 62: year old woman, immigrant from Guatemala with no records; says she got usual shots. What would you do? 1. Order tests for rubella, measles, and varicella antibodies before immunizing 2. Obtain detailed clinical history of possible childhood infections 3. Offer vaccines without tests given that immunization rate is low 4. Obtain medical record documentation or immunization card 5. Ask about possible social contacts before giving live viral vaccines year old woman traveling to South Africa in May for 3 months and asks about need for vaccines. Besides advising her to check the CDC web site, are any of the following NOT needed? 1. Tetanus booster if more than 10 years from last dose 2. Influenza vaccine 3. Hepatitis A vaccine in two doses if not previously given or one dose if > 10 years 4. Hepatitis B series 5. Meningococcal C vaccine year old man with diabetes and hypertension for routine visit. Which of the following do you recommend? 1. Tetanus booster with acellular pertussis last Td was 3 years ago 2. Intra-nasal Influenza vaccine 3. Pneumococcal vaccine booster originally given at age Zoster vaccine without checking antibodies 5. Zoster vaccine only if no prior shingles and with documented positive varicella Ab 10
3 Summary of Presentation Pertussis vaccine revisited Varicella Zoster Vaccine Influenza & Pneumonia vaccines Hepatitis A and B Measles, Mumps, Rubella Human Papilloma Virus vaccine New Information from Today Pertussis vaccine for 65 y + Varicella Zoster Vaccine at 50? Pneumonia vaccine for asthma Pneumococcal conjugate vaccine for selected adults Hepatitis B vaccine for persons with diabetes Human Papilloma Virus vaccine 2 doses may be good enough Pertussis not just for children anymore Pertussis Tdap for Adults
4 Pertussis Vaccine Original - whole cell vaccine consisting of killed organisms Acellular vaccine contains purified, detoxified antigens Childhood DTaP: diptheria toxoid, tetanus toxoid, and acellular pertussis Adult/adolescent Td and Tdap: tetanus + reduced dose diptheria +/- reduced dose pertussis antigens Tetanus and Diphtheria Toxoid + Acellular Pertussis Vaccine (Tdap) Available as of June 2005 Replace Td with Tdap in adolescents at age or give as single dose by 18 y Tdap should replace Td in adults y as a one-time dose as part of primary series or as routine booster Administer to adults caring for children <1 year and all staff with direct patient contact at any age May be done at any time CDC, Updated recommendations MMWR 2011; 60:13 Pertussis Vaccine What s the Evidence? 2781 subjects aged randomized to reduced dose of acellular pertussis vaccine or hepatitis A placebo Followed for 2.5 years Based on primary pertussis definition (cough and positive culture/pcr), vaccine 92% effective Ward JL et al. NEJM, 2005;353(13) Varicella Zoster Virus Vaccine Prevention of Chicken Pox Disease and Mortality Vaccine to Prevent Shingles and Neuralgia
5 Varicella Mortality Incidence decreased by 70% to 80% between 1995 and 2001 Mortality decreased by 66%: 0.41 to 0.14 per million persons Benefit clear in persons < 50 yrs Benefit in all racial and ethnic groups Immunization program against varicella led to fewer deaths A Vaccine for Zoster Pathogenesis- Varicella >90% in U.S. serologic + Sensory nerves to Dorsal Root Ganglia Cell Mediated Immunity Reactivation Incidence >75yrs: 2-3/1000 yrs Lifetime risk 10-20% PHN pain > 30 days Nguyen, NEJM 2005; 352: Zoster Adult Immunization Live attenuated Oka/Merck Zoster Vaccine 20-60K cfu (1350 cfu in varicella vaccine) RCT n=38,546 healthy >60 years old, VZI + (Zoster shot) (placebo) 315 (1.6%) cases 642 cases (3.3%) 61.1 RRR 27 (8.6%) cases PHN No zoster cases had vaccine virus detectable in lesions 80 (12.5%) cases PHN NEJM 352;22 June 2, RRR No serious difference in group side effects Varicella Zoster Vaccine Frozen for storage, administered immediately after reconstitution Cost of vaccine is $150-$200 Decrease in pain burden by 61% Vaccinate 17 people to prevent 1 case of zoster $3,330 Vaccinate 31 to prevent 1 case of post-herpetic neuralgia $6,405 Adverse events sub-study: local 16% vs. 48%; no hospitalization or death differences at 3.4 years Kimberlin DW. NEJM, 2007;356 Simberkoff S, Ann Intern Med 2010; 152: 545
6 Barriers to Use of Zoster Vaccine National survey of primary care MDs 72% response: 301 GIM and 297 FM 49% stock and deliver in their office 36% refer to purchase and bring back 33% refer to a pharmacy for shot 88% recommend HZV; 41% strongly 45% aware Medicare part D covers Reimbursement issues 12% stopped Hurley L, et al. Ann Intern Med 2010; 152: Varicella Zoster Vaccine Vaccinate once at age 60 No need to check for evidence of varicella immunity FDA approved VZV for adults at age 50, but CDC is not recommending If high coverage with childhood varicella vaccine, what happens to Zoster? Patients with previous shingles Adult Vaccines Did Not Precipitate Acute Cardiac Events or Strokes Influenza and Pneumonia Seasonal Flu H1N1 Pneumococcal Vaccine British study of 20,486 patients with MI and 19,063 cases of stroke No increase in risk of MI or stroke after vaccination against the flu, pneumococcal disease and tetanus There was an increased risk in the 3 days after a systemic respiratory infection RR = 4.95 (4.43 a 5.53) Smeeth, NEJM, 2004; 351:
7 Seasonal Influenza Vaccine: The Evidence to Support Use RCT of 1952 healthy adults age during of Inactivated vs. live attenuated vaccine Absolute efficacy of inactivated vaccine was 73% Absolute efficacy of the live vaccine was 51% Monto AS, et al. NEJM, 2009;361. Influenza Vaccine Priority Recommendations Persons 50 years of age and older Residents of chronic care facilities Chronic cardiopulmonary disorders Chronic metabolic diseases, renal dysfunction, hemoglobinopathies, or immunosuppression requiring regular medical follow up Women who will be in 2nd or 3rd trimester of pregnancy Universal Immunization Recommended Seasonal Flu Vaccine for All Persons Effectiveness of Influenza Vaccine (Nichol KL, et al. NEJM 2007; 357: ) Pooled data, 18 cohorts from to ,872 person-seasons of observations 58% vaccinated; mean age 73; 43% men High-risk conditions more prevalent by among vaccinated (56% vs 46%) 27% (OR= 0.73; ) reduction in hospitalizations (all but 1 season) 48% (OR=0.52; ) reduction in risk of death present in all seasons 1 death prevented for every 302 flu shots!
8 Influenza Vaccine Points Flu vaccine for Health Care Workers helps patients: 17% vs. 10% mortality in study of SNF in Scotland Survey in of 2348 health care workers: 66.9% vaccinated (86% MDs) Decline in GBS cases from 0.17 to 0.04 per 100,000 coincided with stepped up food safety interventions and 28% decline in campylobacter infections 65% adults >65 vaccinated, 50% for Latinos and Blacks, more if MD contact Automatic orders work Influenza A H1N1 April 21, 2009: CDC confirms 2 in CA Segments from previous swine influenza viruses June 11, 2009: 30,000 cases across 74 countries WHO issues phase 6 alert = official pandemic is now over! Pneumococcus - Background Risk factors for invasive disease Age >65 or <2 years People with chronic illness Crowding Chronic use of Proton Pump Inhibitors Antecedent respiratory infection and recent antibiotic Smokers African Americans and American Indians Pneumococcal Vaccine Indications All persons older than 65 y 50 y? Chronic cardiovascular disease Chronic pulmonary disease + asthma Diabetes mellitus, smokers Cirrhosis, Alcoholism, CSF leaks Functional or anatomic asplenia HIV infection Immunocompromised persons MMWR1997; 46:1-24 (RR-8)
9 Pneumococcal vaccine Re- Vaccination: CDC Only one-time re-vaccination at 5 years recommended for: no spleen - functional or anatomical chronic kidney disease immune suppressed conditions chemotherapy with cancer drugs Persons at age 65 years if first dose was given 5 years before Otherwise--Re-vaccination not needed! Efficacy of Pneumococcal Vaccine Randomized trials showed no decrease in death or bacteremia; 50% decrease in pneumonia Case control studies--60% to 70% protective efficacy for bacteremia CDC cohort analysis: 57% (95% CI= 45%-66%) protection, sustained over time Vaccine cost effective: saves money and lives even after including future costs Pneumococcal Conjugate Vaccine Used for infants in the US since 2000 Cases of drug resistant Strep Pneumo invasive disease decreased (cases /100,000) Penicillin resistant Muliple Abx resistant Decline of 50% among adults 65 years and older NEJM 2006;354: Recommendation of Pneumococcal Conjugate (PCV13) Vaccine in Adults More immunogenic, 3X more expensive PCV13 first, followed by PPSV23 8 weeks later If already received PPSV23, give PCV13 1 yr later; boost once at 5 years if given < 65 y Conditions: CSF leak, cochlear implant Sickle cell disease, asplenia HIVn infection, chronic renal failure, nephrotic syndrome, leukemia, lymphoma, Hodgkin disease, myeloma, solid organ transplant, iatrogenic immunosuppression CDC, MMWR 2012; 61:
10 Global Burden of Illness of Hepatitis B Hepatitis Vaccines Prevention of Acute and Chronic Hepatitis and Cancer! 2 billion persons with hepatitis B 350 million chronic carriers 1 million deaths per year HBV vaccination programs have been implemented in > 100 countries Reduction of chronic infections and liver cancer Most of chronic infections are acquired as children Hepatitis B Vaccination 2006: 13,200 acute cases, 1460 hospitalized, 47 deaths; 2007: 1815 deaths from chronic HBV Adults target sexually active, health care workers, injection drug users, ESRD, diabetes < 60 y Needle exchange programs are effective Immunity = >10 U/ml anti-hbs Check post-vaccination serology 1-2 m after series in selected patients Universal vaccination is the goal HBV Vaccination Protection Antibody (HBsAb) levels decline to undetectable by 6 yrs. in up to 50% Initial non-responders re-vaccinated with one more dose 15% to 25% respond three more doses 50% to 75% respond No documented case of symptomatic hepatitis in vaccine recipient with initial antibody response Long incubation of HBV allows triggering T cell memory Boosters are not routinely recommended
11 Hepatitis A Vaccination Only 19.7% of adults 19 to 49 years with chronic liver conditions have received 2 doses of hepatitis A vaccine Target: Injection drug users Patients with chronic liver disease Travelers to high/intermediate risk areas in LMIC Household contacts adoptees Measles, Mumps, Rubella Have you ever seen a case? Status of MMR Diseases in 2006 Measles 55 cases; no deaths Global: 242,000 deaths; 68% reduction from 2000 Mumps 6584 cases; no deaths Rubella 11 cases; no deaths; 1 CRS Measles, Mumps, Rubella Vaccine Use combined MMR vaccine in most people Born after 1957 limited exposure Documentation of vaccine receipt; Clinical diagnosis of disease documented or Serologic evidence of immunity Health care workers a priority Non-infectious clinical syndromes No evidence for autism association
12 Human Papilloma Virus Vaccine Cancer Prevention at its Best? Human Papilloma Virus HPV causes cervical cancer (90%+) 50% of adults are infected with HPV 13,000 cases of cervical cancer per year in the US; 3700 deaths High burden of disease in low and middle income countries HPV is not curable or treatable $2 billion dollars to prevent up to 7000 cases of cervical cancer if vaccine is 100% effective HPV Vaccine Efficacy Prevention of warts, persistent HPV infection, and HGSIL lesions Lag time to detect efficacy in prevention of cervical cancer will be 10 to 20 years CIN 2 or CIN 3: about 40% progress to cervical cancer Near 100% effective at decreasing HGSIL of cervix in published trials HPV 16/18 include about 70% of oncogenic HPV types but varies by country HPV Vaccine Recommendations by CDC/ACIP and the ACS All girls at age 9 to 11 years or as adolescents (CDC) All Women 18 to 26 years (not ACS) Give before onset of sexual activity Not to be administered during pregnancy Boys at age 11-12; if not done Adverse effects: minor local reactions, low-grade fever, fainting Cost is about $360 it is covered
13 HPV Vaccine Phase 3 Trials: Futures I and II HPV 16/18 + 6/11 vaccine 12,167 and 5455 women age y; 3 years follow up Per-protocol analysis = no viral evidence of infection by month 7 CIN grade 2 or 3 or cancer Efficacy = 98% (86 to 100) Intention to treat efficacy = 44% (26 58) or 34% (15 to 49) Efficacy for all CIN 2/3 or cancer was only 17% (1 to 31) or 20% (8 to 31) HPV Vaccine Questions Duration of immunity unknown Acceptability by parents? Reassurance regarding safe sex? Cover more oncogenic types? Alter routine Pap screening? Global Application? 21% of women age had received HPV in 2010 HPV Vaccine In Older Women Women aged yrs, randomized, placebo-controlled, double-blind study with no h/o genital warts or cervical disease 3817 women received quadrivalent HPV vaccine vs. placebo 3 doses Outcome=disease/infection related to HPV 6, 11, 16, 18 Efficacy 90.5%, but ITT efficacy: 30.9% Munoz N, et al. Lancet, 2009;373 Immunogenicity of 2 Doses of HPV Vaccine in Adolescents Mean Ab levels to HPV-16 and women randomized; girls 9-13 y to either 2 or 3 doses; women y received 3 doses Outcome = geometric mean titer of Ab; non-inferiority up to 36 months No significant difference in GMT Dobson S, et al. JAMA 2013; 309:
14 Patient Reminders for Immunizations Are effective: 5% to 20% absolute increase in 33 of 41 RCT Immunization rate: 42% vs. 27% Influenza, pneumococcal, tetanus All ages--children do better Academic > private or public clinic Telephone is most effective, costly Mailed postcards and auto-dials OK Immunization Information Resources CDC Travel Advisory National Immunization Program National Vaccine Program Office Immunization Action Coalition
Deaths/yr Efficacy Use Prev Deaths/yr. Influenza 36,000 70% 60% 18,000. Pneumonia 40,000 60% 40% 20,000 HBV 6,000 90% 30% 4,000
Tetanus, Diptheria, Pertussis,! Measles, Mumps, Rubella, Varicella, HPV, Polio Meningococcus, Pneumococcus,! Influenza, Hepatitis B, Hepatitis A,! H influenza, Rabies, Typhoid,! Yellow Fever, Japanese
More informationVaccinations for Adult and Adolescent Women
Vaccinations for Adult and Adolescent Women Eliseo J. Pérez-Stable, MD Professor of Medicine DGIM, Department of Medicine University of California, San Francisco July 3, 2013 Declaration of full disclosure:
More informationVaccinations for Adults
Case: Vaccinations for Adults Lisa Winston, MD University of California, San Francisco San Francisco General Hospital A 30-year old healthy woman comes for a routine visit. She is recently married and
More informationSeries of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)
UTAH PREVENTIVE CARE RECOMMENDATIONS Adult - Ages 19 and Above IMMUNIZATIONS CONTENTS: General Instructions Hepatitis A Hepatitis B Human Papilloma Virus Influenza Meningococcal A, C, Y, W (MCV4) Meningococcal
More information11/17/2013 THE WHO, WHAT, WHEN, AND WHY OF ADULT VACCINATIONS. Pneumococcal Vaccines for Adults (PPV) Pneumococcal Vaccines
THE WHO, WHAT, WHEN, AND WHY OF ADULT VACCINATIONS CAROL A. KAUFFMAN, MD VA ANN ARBOR HEALTHCARE SYSTEM UNIVERSITY OF MICHIGAN Will discuss: bacterial vaccines made of toxoids or polysaccharide capsular
More information! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital! Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted! Traditionally
More informationKatherine Julian, MD July 1, Vaccines Generally Available in the U.S. U.S.
Katherine Julian, MD July 1, 2008 Vaccines Generally Available in the U.S. Vaccines Generally Available in the U.S. Vaccines for Special Populations Plague Tularemia Smallpox Anthrax Botulism Tuberculosis
More information4/7/13. Vaccinations for Adults and Adolescents. Effect of Full Use of Adult Immunizations. General Vaccine Information
Vaccinations for Adults and Adolescents Nicholas A. Daniels, MD MPH Department of Medicine Professor of Clinical Medicine Declaration of full disclosure: No conflict of interest 2 Effect of Full Use of
More informationImmunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H.
Immunizations to Reduce Disease H. Keipp Talbot, M.D., M.P.H. Vanderbilt University School of Medicine 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationPreventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.
Vaccinations for Adults: An Update Preventative Vaccines Need to be extremely safe Even greater issue as disease prevalence wanes or uncommon diseases targeted Lisa G. Winston, MD University of California,
More informationVaccines for Primary Care Pneumococcal, Shingles, Pertussis
Vaccines for Primary Care Pneumococcal, Shingles, Pertussis Devang Patel, M.D. Assistant Professor Chief of Service, MICU ID Service University of Maryland School of Medicine Pneumococcal Vaccine Pneumococcal
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More information2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle
2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster
More informationTDCJ OFFENDER IMMUNIZATION GUIDELINES
TDCJ OFFENDER IMMUNIZATION GUIDELINES B-14.07 Immunizations Attachment A VACCINE WHO GETS IT * WHEN THEY GET IT DOSE/ROUTE HPV Vaccine Females age 9 to 26 years if not previously vaccinated. On Intake
More informationA. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010
Who do you think received the most immunologic components in vaccines? Development of which vaccine slowed after the invention of antibiotics? A. Children born in 1942 B. Children born in 1982 C. Children
More informationUpdate on Immunizations H. Keipp Talbot, M.D., M.P.H.
Update on Immunizations H. Keipp Talbot, M.D., M.P.H. Vanderbilt University Medical Center 1 DISCLOSURES Financial Relationships with Relevant Commercial Interests Receive research funding from Sanofi
More informationEssential Vaccinations for HIV-Positive Adults and Adolescents
Essential Vaccinations for HIV-Positive Adults and Adolescents Janak A. Patel, MD Professor & Director, Pediatric Infectious Diseases Director, Maternal-Child Program University of Texas Medical Branch
More informationImmunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationImmunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More information2/20/2019. The need for adult vaccinations. Update on Adult Immunizations. The Need for Adult Vaccinations. Objectives:
The need for adult vaccinations Update on Adult Immunizations Objectives: Recall the latest recommendations on adult vaccinations Detail the importance of adult vaccinations I m not a kid.. Why are you
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years United States, 2014. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations
More informationVaccine Preventable Diseases Among Adults
Vaccine Preventable Diseases Among Adults Stephanie Borchardt, MPH, PhD Wisconsin Immunization Program Division of Public Health Wisconsin Department of Health Services November 17, 2016 At a Glance Burden
More informationStreptococcus pneumoniae CDC
Streptococcus pneumoniae CDC Pneumococcal Disease Infection caused by the bacteria, Streptococcus pneumoniae» otitis media 20 million office visits (28-55% Strep)» pneumonia 175,000 cases annually» meningitis
More informationVACCINATION FOR WOMEN (ADOLESCENCE TO SENESCENCE)
VACCINATION FOR WOMEN (ADOLESCENCE TO SENESCENCE) Dr.T.K.SHAANTHY GUNASINGH M.D., D.G.O., FICOG PROFESSOR AND HEAD OF THE DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY PROGRAMME DIRECTOR CENTRE OF EXCELLENCE
More informationVaccines, Not Just for Babies
Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in
More informationPublic Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.
ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.
More informationUpdate on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017
Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More informationImmunization Guidelines for the Use of State Supplied Vaccine May 17, 2015
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Preventative Vaccines
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Preventative Vaccines Diseases/Pathogens
More informationAdult Immunization Update 2015
Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More informationAdult Immunization Rates
Adult Immunization Rates California Immunization Coalition Summit May 5, 2014 Eileen Yamada, MD, MPH California Department of Public Health Immunization Branch Adult Immunization Rates California Data
More informationPatient Immunization FAQ Sheet
Patient Immunization FAQ Sheet Shingles Vaccine: Q: Who should get the shingles vaccine (Zostavax )? A: Anyone 60 years of age or should get the shingles (herpes zoster) vaccine. There is no maximum age
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationBenefit Interpretation
Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents
More informationRoutine Adult Immunization: American College of Preventive Medicine Practice Policy Statement, updated 2002
Routine Adult Immunization: American College of Preventive Medicine Practice Policy Statement, updated 2002 Ann R. Fingar, MD, MPH, and Byron J. Francis, MD, MPH Burden of suffering Vaccines are available
More informationImmunizations Offered
Immunizations Offered Most vaccines commercially available in the United States are available at the health clinic. A partial list of available vaccines follows. For more information about specific vaccines
More informationVaccines Indicated for Infants, Children, and Adolescents Based on Medical and Other Indications
Vaccines Indicated for Infants, Children, and Adolescents Based on Medical and Other Indications Vaccine Prematurity 1 Altered Immunocompetence 2 (excluding human immunodefi ciency virus [HIV] infection)
More informationVaccines Generally Available in the U.S. Vaccines Generally Available in the U.S. 8/5/2013
Katherine Julian, MD Professor of Clinical Medicine, UCSF August 5, 2013 Vaccines Generally Available in the U.S. Tetanus Diptheria Pertussis Measles Mumps Rubella Varicella Meningococcus Pneumococcus
More informationVACCINE DIALOGUE AIDC 2017
VACCINE DIALOGUE AIDC 2017 Idea is Not to discuss about each vaccine Discuss about when to use- clinical situations Allaying the fears ADULT VACCINES Question What are the current CDC recommendations on
More informationImmunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR
Immunizations June 5, 2015 Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR Disclosures None Goals Understand basic public health impact of immunization Recognize types
More informationJon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health
Jon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health University of Wisconsin School of Medicine and Public Health Grand Rounds September
More informationAdult Immunizations: Ensuring Family Planning Clients are Protected
Objectives Adult Immunization: Identify the recommended vaccines for adults Identify three functions of the Michigan Care Improvement Registry (MCIR) Discuss vaccine procurement options for adults Barbara
More informationKeeping up with immunizations for adults
MEDICAL GRAND ROUNDS CME CREDIT EDUCATIONAL OBJECTIVE: Readers will vaccinate their patients according to guidelines from the US Centers for Disease Control and Prevention CRAIG NIELSEN, MD Associate Professor,
More informationVaccines and Adults: Our Collective Challenge Webinar
Vaccines and Adults: Our Collective Challenge Webinar Questions 1. What documentation would a pediatrician need to immunize adult parents to avoid some risk since they are non-patients of the practice
More informationPoint/Counterpoint. Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI
Point/Counterpoint Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI It s Influenza Season A couple in their 40s comes to your clinic in early August and asks about influenza vaccine. It is being offered
More informationVaccines in Immunocompromised hosts
Vaccines in Immunocompromised hosts Carlos del Rio, MD Emory Center for AIDS Research October 2013 Immunocompromised hosts Number has increased rapidly in the past decades Broad term that encompasses different
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Diseases/Pathogens with Vaccines for Special Populations.
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationImmunization Update for Health System Pharmacists Eric Crumbaugh, PharmD
Immunization Update for Health System Pharmacists 2015 Eric Crumbaugh, PharmD Financial Disclosures Eric Crumbaugh, PharmD Speaker s Bureau Merck Vaccines Pfizer Consultant Pfizer Novartis Merck Objectives
More informationImmunizations. Update Immunizations through Time. Learning Objectives. Presenter Disclosure Information. 10:30 11:45am. Immunization Update
10:30 11:45am Immunization Update SPEAKER John Russell, MD Presenter Disclosure Information The following relationships exist related to this presentation: John Russell, MD, serves on Speaker s Bureau
More informationUpdate on Adult Immunization Strategies: Understanding the Current Recommendations
Update on Adult Immunization Strategies: Understanding the Current Recommendations EDWARD A. DOMINGUEZ, MD, FACP, FIDSA Medical Director, Organ Transplant Infectious Diseases Methodist Dallas Medical Center,
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationAdult Vaccine Update. NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH
Adult Vaccine Update NB Internal Medicine Update, April 22 nd, 2016 Dan Smyth, MD, FRCPC, DTMH Summary points: Canadian adults > 18 should be regularly assessed to ensure recommended vaccinations are up
More informationNeedle Facts: Immunization Update Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy
Needle Facts: Immunization Update 2015 Mirada Wilhelm, PharmD Clinical Associate Professor SIUE School of Pharmacy Objectives Pharmacists At the conclusion of this program, the pharmacist will be able
More informationMandates and More. Julie Morita, M.D. Deputy Commissioner Chicago Department of Public Health. Chicago Department of Public Health
Mandates and More Julie Morita, M.D. Deputy Chicago Department of Public Health Why are vaccines required for school entry? School Vaccine Requirements Small pox vaccine required in Massachusetts 1855
More information301 W. Alder, Missoula, MT or
301 W. Alder, Missoula, MT 59802 406-258-4745 or 406-258-3363 Routine Immunizations are available on a walk-in basis: Mondays, Tuesdays, Thursdays, and Fridays from 9:00am to 4:30pm Wednesdays, 10:00am-4:30pm
More informationVACCINATIONS AND INFLAMMATORY BOWEL DISEASE
VACCINATIONS AND INFLAMMATORY BOWEL DISEASE Bob Kizer MD Assistant Professor of Medicine Creighton University School of Medicine CONFLICTS OF INTEREST None 1 AN OPPORTUNITY FOR IMPROVEMENT IBD patients
More informationUpdate on Adult Immunization
Update on Adult Immunization Paul J. Carson, MD, FACP Sanford Health, Infectious Disease NDSU Master of Public Health Program UND School of Medicine and Health Sciences When meditating over a disease,
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Outline vaccines to be covered
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationVaccine Overview. Quick and Dirty Version
Vaccine Overview Quick and Dirty Version Key Points Random Facts Vaccine Schedule Types of Vaccines 7 Rules of vaccinations Vaccine Updates VACCINATIONS ARE IMPORTANT Never miss an opportunity to vaccinate!!!
More informationDownload CoCASA Software Application
Comprehensive Clinic Assessment Software Application (CoCASA) 7.0 Instructions Guide for Immunization Service Contractors February 6, 2012 The Comprehensive Clinic Assessment Software Application (CoCASA)
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women March 2012 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) MARCH 2012 Risk
More informationRecommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2016 This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended
More informationImmunization Recommendations for College Students
May 2017 ACHA Guidelines Immunization Recommendations for College Students Immunizations offer safe and effective protection from vaccine-preventable diseases and outbreaks. The United States is experiencing
More informationAdolescent Immunizations
Adolescent Immunizations Preteen Vaccine Week Webinar January 23, 2008 Eileen Yamada, MD, MPH California Department of Public Health Immunization Branch Younger Children AND Adolescents Need Immunizations!
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationIMMUNIZATIONS IN WOMEN 2014
IMMUNIZATIONS IN WOMEN 2014 Carol E. Hayes, CNM, MN, MPH American College of Nurse Midwives representative to CDC Advisory Committee on Immunization Practice (ACIP) Myths Vs Facts See Talking Point document
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Diseases/Pathogens with Vaccines for Special Populations
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationImmunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
More informationPreventive care guidelines for children and adults.
Preventive care guidelines for children and adults. Keeping a focus on regular preventive care can help you and your family stay healthy. Preventive care can help you avoid potentially serious health conditions
More informationWhat are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
More informationYoung Adults (Ages 18 26)
Young Adults (Ages 18 26) Vaccines help prevent many diseases. Some new vaccines are available today that were not in use just a few years ago. By protecting yourself, you help protect everyone around
More informationAmerican Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida
Vaccine policy in the US Disease Prevention and Control: Vaccination Recommendations and Travel Medicine Update Lisa A. Klatka, DO, MS Medina County Health Department Medina, OH Manufacturers publish product
More informationImmunization of Adults in High Risk Populations. Carol A. Kurbis MD, CCFP, FRCPC WRHA Medical Officer of Health
Immunization of Adults in High Risk Populations Carol A. Kurbis MD, CCFP, FRCPC WRHA Medical Officer of Health OBJECTIVES To review recommendations for immunization in adult populations, with a focus on
More information2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS
IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient
More informationMOLINA HEALTHCARE OF TEXAS
MOLINA HEALTHCARE OF TEXAS Preventive Care Guidelines: Ages 21 and Older GUIDELINE Molina Healthcare of Texas has adopted Preventive Care Guidelines: Ages 21 and Older. The guideline was reviewed and adopted
More informationChildhood Immunization Status
emeasure Title emeasure Identifier (Measure Authoring Tool) Childhood Immunization Status 117 emeasure Version number 5.1.000 NQF Number 0038 GUID b2802b7a-3580-4be8-9458- 921aea62b78c Measurement Period
More informationGuidelines for Vaccinating Pregnant Women
Guidelines for Vaccinating Pregnant Women April 2013 Guidelines for Vaccinating Pregnant Women Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP) April 2013 Risk
More informationPreventive Care ALASKA NATIVE HEALTH STATUS REPORT 13
Preventive Care ALASKA NATIVE HEALTH STATUS REPORT 13 14 ALASKA NATIVE HEALTH STATUS REPORT Highlights Approximately half (56.5%) of Alaska Native adults received dental care in the past year. Approximately
More informationImmunization Update Richard M. Lampe M.D.
Immunization Update 2012 Richard M. Lampe M.D. Immunization Update List the Vaccines recommended for Health Care Personnel Explain why Health Care Personnel are at risk Recognize the importance of these
More informationVaccines They re not Just for Kids
Mid-Maryland Internal Medicine 187 Thomas Johnson Dr., Suite 4 Frederick, MD 21702 www.midmarylandinternalmedicine.com Vaccines They re not Just for Kids Getting immunized is a lifelong job. Vaccines are
More informationVaccination Guidelines Sipho Dlamini Division of Infectious Diseases & HIV Medicine University of Cape Town Groote Schuur Hospital
Vaccination Guidelines Sipho Dlamini Division of Infectious Diseases & HIV Medicine University of Cape Town Groote Schuur Hospital 4 th Southern African HIV Clinicians Society Conference / 24-27 October
More informationPhysicians Update 1 September 2015 From the Office of the Chief Medical Health Officer
1 September 2015 Immunization Bulletin (Please share with your medical office assistants) 1. New publicly funded vaccines a. Expanded eligibility for free HPV vaccine for select males 9-26 years of age
More informationNothing to disclose. Vaccinations for Adults and Adolescents: An Update. Key Resource
Vaccinations for Adults and Adolescents: An Update Nothing to disclose. Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital
More informationVice Chancellor, Health Affairs & Dean, School of Medicine Vice Chancellor & Dean s Office Origination Date: 05/20/2013 Date of Revision: Scope:
UC Riverside, School of Medicine Policies and Procedures Policy Title: Vaccination and Immunization Requirements Policy Number: SOM 4.0 Responsible Officer: Responsible Office: Vice Chancellor, Health
More informationPrevention of and Treatment Of Infection In IBD
Prevention of and Treatment Of Infection In IBD Gil Y. Melmed, MD Cedars Sinai Medical Center CCFA Advances in IBD, 2011 Risk of Infection in IBD Infections are the most common significant adverse event
More informationSummary of Recommendations for Adult Immunization (Age 19 years and older) (Page 2 of 5)
Summary of Recommendations for Adult Immunization (Age 19 years and older) (Page 1 of 5) Influenza Inactivated Influenza (IIV*) or ID (intradermally) *includes recombinant influenza (RIV) Live attenuated
More informationImmunization across the age span: What s new and/or improved?
Immunization across the age span: What s new and/or improved? PICNet 2018 Educational Conference March 9 2018 Monika Naus MD MHSc FRCPC FACPM BC Centre for Disease Control School of Population and Public
More informationBODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES
BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES Topic 3 This topic links in with MICROBES (from unit 1) 1. What are the 3 types of microbes? 2. Which microbe do antibiotics destroy? 3. What microbe
More informationObjectives. Immunity. Diphtheria. Immunization Update July 22, Individual Immunity
Immunization Update July 22, 2008 Presented by Robert Brayden, MD Associate Professor, UCHSC Child Health Clinic, The Children s s Hospital Hosted by: Community Health Association of Mountain/Plains States
More informationNothing to disclose.
Vaccinations for Adults and Adolescents: An Update Lisa G. Winston, MD Professor of Medicine, University of California, San Francisco Vice Chief, Inpatient Medical Services and Hospital Epidemiologist
More informationImmunization in Cancer Patients:
Immunization in Cancer Patients: An Often Forgotten or Ignored Responsibility E.J. Bow MD, MSc., D. Bacteriol., FRCPC Infectious Diseases, Haematology/Oncology, Blood and Marrow Transplant Director, Infection
More informationImmunization Update. 23 rd October Natasha S. Crowcroft Chief, Infectious Diseases Public Health Ontario
Immunization Update 23 rd October 2013 Natasha S. Crowcroft Chief, Infectious Diseases Public Health Ontario Immunization: It s Your Best Shot! Faculty/Presenter Disclosure Faculty: Dr. Natasha Crowcroft
More information10/16/2018. Be Discuss. Describe. Discuss. Discuss 2018 ADULT IMMUNIZATION SCHEDULE INFLUENZA ADULT IMMUNIZATION UPDATE TRAINING OBJECTIVES FLUMIST
ADULT IMMUNIZATION UPDATE NORTH DAKOTA ACADEMY OF FAMILY PHYSICIANS NOVEMBER 10, 2018 Be Discuss Upon completion of the adult immunization training, participants will be able to: Discuss the general adult
More information